Difference between revisions of "Timeline of vaccines"

From Timelines
Jump to: navigation, search
 
(35 intermediate revisions by the same user not shown)
Line 220: Line 220:
 
|-
 
|-
 
| 2006 || || || Organization || The {{w|Collaboration for AIDS Vaccine Discovery}} is founded when the {{w|Bill & Melinda Gates Foundation}} donates US$287 million to promote HIV vaccine research. The organization is an international network of scientists, research organizations, and promoters of HIV vaccine research.<ref>{{cite web |url= http://www.dukehealth.org/health_library/news/9803 |title=Gates Foundation Funds Major New Collaboration to Accelerate HIV Vaccine Development - DukeHealth.org |first= |last= |work=dukehealth.org |year=19 July 2006|accessdate=31 May 2018}}</ref> ||  
 
| 2006 || || || Organization || The {{w|Collaboration for AIDS Vaccine Discovery}} is founded when the {{w|Bill & Melinda Gates Foundation}} donates US$287 million to promote HIV vaccine research. The organization is an international network of scientists, research organizations, and promoters of HIV vaccine research.<ref>{{cite web |url= http://www.dukehealth.org/health_library/news/9803 |title=Gates Foundation Funds Major New Collaboration to Accelerate HIV Vaccine Development - DukeHealth.org |first= |last= |work=dukehealth.org |year=19 July 2006|accessdate=31 May 2018}}</ref> ||  
 +
|-
 +
| 2006 || || || Organization || The {{w|Global action plan for influenza vaccines}} is launched as a 10-year initiative by the {{w|World Health Organization}}, with the purpose to reduce the global shortage and inequitable access to influenza vaccines in the event of an influenza pandemic.<ref name="saawe">{{cite web |title=4th International Conference on Influenza and Zoonotic Diseases |url=https://influenza.infectiousconferences.com/abstract/2018/global-pandemic-influenza-vaccine-preparedness-progress-under-the-global-action-plan-for-influenza-vaccines-and-next-steps |website=influenza.infectiousconferences.com |accessdate=30 June 2020}}</ref><ref>{{cite web |title=3rd WHO Consultation on Global Action Plan for Influenza Vaccines, November 2016 |url=https://www.who.int/influenza_vaccines_plan/news/gap3_Nov16/en/ |website=who.int |accessdate=30 June 2020}}</ref>
 
|-
 
|-
 
| 2007 (February 9) || || || Program || Five countries ({{w|Canada}}, {{w|Italy}}, {{w|Norway}}, {{w|Russia}}, the {{w|United Kingdom}}), and the {{w|Bill & Melinda Gates Foundation}} commit US$1.5 billion to launch the first {{w|Advance Market Commitment}} (AMC) with the purpose of accelerating access to vaccines against pneumococcal disease.<ref>{{cite web |title=GAVI partners fulfill promise to fight pneumococcal disease |url=https://www.gavi.org/library/news/press-releases/2009/gavi-partners-fulfill-promise-to-fight-pneumococcal-disease/ |website=gavi.org |accessdate=1 June 2018}}</ref> ||
 
| 2007 (February 9) || || || Program || Five countries ({{w|Canada}}, {{w|Italy}}, {{w|Norway}}, {{w|Russia}}, the {{w|United Kingdom}}), and the {{w|Bill & Melinda Gates Foundation}} commit US$1.5 billion to launch the first {{w|Advance Market Commitment}} (AMC) with the purpose of accelerating access to vaccines against pneumococcal disease.<ref>{{cite web |title=GAVI partners fulfill promise to fight pneumococcal disease |url=https://www.gavi.org/library/news/press-releases/2009/gavi-partners-fulfill-promise-to-fight-pneumococcal-disease/ |website=gavi.org |accessdate=1 June 2018}}</ref> ||
Line 225: Line 227:
 
| 2007 (September 1) || || || || "On September 1, 2007, the U.S. [[Food and Drug Administration]] (FDA) licensed a new [[vaccine]] [[ACAM2000]] against [[smallpox]] which can be produced quickly upon need. Manufactured by [[Sanofi Pasteur]], the U.S. [[Centers for Disease Control and Prevention]] stockpiled 192.5 million doses of the new vaccine (see list of common strains below).<ref>{{cite news |url=https://www.chron.com/news/nation-world/article/FDA-approves-new-smallpox-vaccine-1833591.php |title=FDA approves new smallpox vaccine |last=Heilprin |first=John |agency=AP |website=Houston Chronicle |date=1 September 2007 |access-date=25 May 2018}}</ref>" || {{w|United States}}
 
| 2007 (September 1) || || || || "On September 1, 2007, the U.S. [[Food and Drug Administration]] (FDA) licensed a new [[vaccine]] [[ACAM2000]] against [[smallpox]] which can be produced quickly upon need. Manufactured by [[Sanofi Pasteur]], the U.S. [[Centers for Disease Control and Prevention]] stockpiled 192.5 million doses of the new vaccine (see list of common strains below).<ref>{{cite news |url=https://www.chron.com/news/nation-world/article/FDA-approves-new-smallpox-vaccine-1833591.php |title=FDA approves new smallpox vaccine |last=Heilprin |first=John |agency=AP |website=Houston Chronicle |date=1 September 2007 |access-date=25 May 2018}}</ref>" || {{w|United States}}
 
|-
 
|-
| 2009 (September) || || || Vaccine || The United States {{w|FDA}} approves four vaccines against the {{w|Influenza A virus subtype H1N1}}.<ref name="Vaccine Timeline"/> ||
+
| 2009 || September 15 || {{w|Influenza}} || Vaccine approval || The United States {{w|FDA}} approves four vaccines against the {{w|Influenza A virus subtype H1N1}}.<ref>{{cite web |title=FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine |url=https://www.gsk.com/en-gb/media/press-releases/fda-approves-cervarix-glaxosmithkline-s-cervical-cancer-vaccine/ |website=gsk.com |accessdate=3 June 2020}}</ref><ref>{{cite web |title=Update on Influenza A (H1N1) 2009 Monovalent Vaccines |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5839a3.htm |website=cdc.gov |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2009 || October 16 || || || "FDA approved new indication for gardasil to prevent genital warts in men and boys."<ref>{{cite web |title=FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys |url=http://www.natap.org/2009/newsUpdates/101709_04.htm |website=natap.org |accessdate=3 June 2020}}</ref> ||
 
|-
 
|-
| 2009 (October) || || || Vaccine || The United States {{w|FDA}} approves {{w|Cervarix}}, by {{w|GlaxoSmithKline}}, for the prevention of {{w|cervical cancer}}.<ref name="Vaccine Timeline"/> ||
+
| 2009 || October 16 || || Vaccine || The United States {{w|FDA}} approves {{w|Cervarix}}, by {{w|GlaxoSmithKline}}, for the prevention of {{w|cervical cancer}}.<ref name="Vaccine Timeline"/> ||
 
|-
 
|-
 
| 2009 || || General || Research || The journal ''[[w:Pediatrics (journal)|Pediatrics]]'' concludes that the largest risk among unvaccinated children is not the contraction of side effects, but rather the disease that the vaccination aims to protect against.<ref name="vaccine refusal">{{cite web |title = Is Vaccine Refusal Worth The Risk? |website = {{w|NPR}} |date = 2009-05-26 |url = https://www.npr.org/templates/story/story.php?storyId=104523437 |accessdate = 1 June 2020 }}</ref> ||
 
| 2009 || || General || Research || The journal ''[[w:Pediatrics (journal)|Pediatrics]]'' concludes that the largest risk among unvaccinated children is not the contraction of side effects, but rather the disease that the vaccination aims to protect against.<ref name="vaccine refusal">{{cite web |title = Is Vaccine Refusal Worth The Risk? |website = {{w|NPR}} |date = 2009-05-26 |url = https://www.npr.org/templates/story/story.php?storyId=104523437 |accessdate = 1 June 2020 }}</ref> ||
 +
|-
 +
| 2009 || December 23 || || || "FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years and older."<ref>{{cite web |title=Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use --- United States, 2010 |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5916a2.htm |website=cdc.gov |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2010 || January 29 || || || "January 29, 2010 WHO hailed new Gates Foundation support ($10 billion) as the "Decade of Vaccines.""<ref>{{cite web |title=WHO hails new Gates Foundation support for decade of vaccines |url=https://www.who.int/mediacentre/news/statements/2010/gates_gavi_20100129/en/ |website=who.int |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2010 || February 19 || || Vaccine approval || "FDA approved licensure of Menveo (Novartis), meningococcal conjugate vaccine for people ages 11 through 55 years."<ref>{{cite book |title=Morbidity and Mortality Weekly Report: MMWR |url=https://books.google.com.ar/books?id=YY6Rckp7dFIC&pg=PA273&lpg=PA273&dq=February+19,+2010+FDA+approved+licensure+of+Menveo+(Novartis),+meningococcal+conjugate+vaccine+for+people+ages+11+through+55+years.&source=bl&ots=9RUYi1Uw2r&sig=ACfU3U14q7tzlS5a_2wtTHjKVjugcwyNxw&hl=en&sa=X&ved=2ahUKEwiKkZm8rebpAhUlGbkGHZ4RCaEQ6AEwAXoECAoQAQ#v=onepage&q=February%2019%2C%202010%20FDA%20approved%20licensure%20of%20Menveo%20(Novartis)%2C%20meningococcal%20conjugate%20vaccine%20for%20people%20ages%2011%20through%2055%20years.&f=false}}</ref> ||
 +
|-
 +
| 2010 || February 24 || {{w|Streptococcus pneumoniae}} || || " FDA approved licensure of Pneumococcal 13-valent conjugate vaccine (PCV13), which offers broader protections against Steptococcus pneumoniae infections."<ref>{{cite web |title=Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm |website=cdc.gov |accessdate=3 June 2020}}</ref><ref>{{cite web |title=Advisory No. 15. The New PCV13 Vaccine |url=https://www.dshs.state.tx.us/immunize/vacadvise/Advisory-15.aspx |website=dshs.state.tx.us |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2010 || July || {{w|Smallpox}} || || "First smallpox vaccine for certain immune-compromised populations delivered under Project BioShield."<ref>{{cite web |title=First Smallpox Vaccine for Special Populations Delivered Under Project BioShield |url=https://www.infectioncontroltoday.com/vaccines-vaccination/first-smallpox-vaccine-special-populations-delivered-under-project-bioshield |website=infectioncontroltoday.com |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2010 || December 22 || {{w|Human papillomavirus infection}} || || "FDA approved Gardasil HPV vaccine to include the indication for the prevention of anal cancer."<ref>{{cite web |title=FDA: Gardasil Approved to Prevent Anal Cancer |url=https://www.prnewswire.com/news-releases/fda-gardasil-approved-to-prevent-anal-cancer-112326644.html |website=prnewswire.com |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2011 || April 22 || Meningococcal disease || Vaccine approval || "FDA approved the first vaccine (Menactra, meningococcal conjugate vaccine, Sanofi Pasteur) to prevent meningococcal disease in infants and toddlers."<ref>{{cite web |title=Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants |url=https://www.eurekalert.org/pub_releases/2011-04/cwgi-set042511.php |website=eurekalert.org |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2011 || July 8 || || || "FDA approved Boostrix (Tdap, GlaxoSmithKline) to prevent tetanus, diphtheria, and pertussis in older people."<ref>{{cite journal |title=FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine |pmid=21937974 |url=https://pubmed.ncbi.nlm.nih.gov/21937974/ |publisher=Centers for Disease Control and Prevention}}</ref> ||
 +
|-
 +
| 2012 || June 5 || || || "U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) released a report titled "Vaccines for Children (VFC) Program: Vulnerabilities in Vaccine Management."<ref>{{cite web |title=VACCINES FOR CHILDREN PROGRAM:  VULNERABILITIES IN VACCINE MANAGEMENT |url=https://oig.hhs.gov/oei/reports/oei-04-10-00430.pdf |website=oig.hhs.gov |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2012 || June || {{w|Meningococcal disease}} || Vaccine approval || "FDA approved HibMenCY (Menhibrix, GlaxoSmithKline), a new combination (meningococcal and Hib) vaccine for infants."<ref>{{cite book |last1=Bennett |first1=John E. |last2=Dolin |first2=Raphael |last3=Blaser |first3=Martin J. |title=Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book |url=https://books.google.com.ar/books?id=73pYBAAAQBAJ&pg=PA2443&lpg=PA2443&dq=FDA+approved+HibMenCY+(Menhibrix,+GlaxoSmithKline)&source=bl&ots=UZkmcARti6&sig=ACfU3U1EVb-80b0EAiXWoCgFRBgCsoGGZw&hl=en&sa=X&ved=2ahUKEwitk8vpyOTpAhVlHrkGHatuAnkQ6AEwBHoECAwQAQ#v=onepage&q=FDA%20approved%20HibMenCY%20(Menhibrix%2C%20GlaxoSmithKline)&f=false}}</ref> ||
 +
|-
 +
| 2012 || April 1 || || || "United Nations Foundation launched Shot@Life campaign."<ref>{{cite web |title=Case Study: The UN Foundation’s Shot@Life Campaign Mobilizes U.S. Moms to Fight Vaccine-Preventable Childhood Diseases |url=https://www.prnewsonline.com/case-study-the-un-foundations-shotlife-campaign-mobilizes-u-s-moms-to-fight-vaccine-preventable-childhood-diseases/ |website=prnewsonline.com |accessdate=3 June 2020}}</ref> ||
 
|-
 
|-
 
| 2012 || || || Vaccine approval || A quadrivalent inactivated influenza vaccine is licensed in the {{w|United States}}.<ref>{{cite web|title=Influenza|url=https://www.historyofvaccines.org/content/articles/influenza|website=historyofvaccines.org|accessdate=26 April 2018}}</ref> ||
 
| 2012 || || || Vaccine approval || A quadrivalent inactivated influenza vaccine is licensed in the {{w|United States}}.<ref>{{cite web|title=Influenza|url=https://www.historyofvaccines.org/content/articles/influenza|website=historyofvaccines.org|accessdate=26 April 2018}}</ref> ||
 +
|-
 +
| 2012 || November 20 || {{w|Influenza}} || Vaccine approval || "FDA approved first seasonal influenza vaccine manufactured using cell culture technology (Flucelvax, Novartis)."<ref>{{cite web |title=A First – Cell Culture Based Seasonal Influenza Vaccine Approved by the FDA |url=https://cellculturedish.com/a-first-cell-culture-based-seasonal-influenza-vaccine-approved-by-the-fda/#:~:text=On%20November%2020%2C%202012%2C%20FDA,vaccine%20in%20the%20United%20States. |website=cellculturedish.com |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2012 || December 12 || {{w|Influenza}} || Vaccine approval || "FDA approved quadrivalent formulation of Fluarix (inactivated influenza vaccine; GlaxoSmithKline)."<ref>{{cite web |title=Quadrivalent flu vaccines coming; companies cite good demand |url=https://www.cidrap.umn.edu/news-perspective/2013/08/quadrivalent-flu-vaccines-coming-companies-cite-good-demand |website=cidrap.umn.edu |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2012 || December 12 || || || "On December 11, 2012, the Institute for Safe Medication Practices (ISMP) issued a press release announcing the launch of its new Vaccine Error Reporting Program. The program allows healthcare professionals to confidentially report vaccine administration errors and near misses. According to the press release, the program's goal is to better quantify sources of errors and advocate for product changes (such as changes to the vaccine name or label) that will ensure patient safety."<ref>{{cite web |title=Issue 1033: January 2, 2013 |url=https://www.immunize.org/express/issue1033.asp |website=immunize.org |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2013 || January 25 || {{w|Pneumococcal disease}} || Vaccine approval || "FDA approved use of Prevnar 13 vaccine in older children and teens (6-17 years)."<ref>{{cite web |title=PFIZER RECEIVES FDA APPROVAL FOR THE USE OF PREVNAR 13 IN VACCINE-NAIVE CHILDREN AND ADOLESCENTS AGED 6 YEARS THROUGH 17 YEARS FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE |url=https://www.pfizer.com/news/press-release/press-release-detail/pfizer_receives_fda_approval_for_the_use_of_prevnar_13_in_vaccine_naive_children_and_adolescents_aged_6_years_through_17_years_for_the_prevention_of_invasive_pneumococcal_disease |website=pfizer.com |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2013 || February 22 || {{w|Tetanus}}, {{w|diphtheria}}, {{w|pertussis}} || Recommendation || "ACIP recommended a dose of Tdap vaccine during each pregnancy."<ref>{{cite web |title=Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012 |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a4.htm |website=cdc.gov |accessdate=3 June 2020}}</ref> ||
 
|-
 
|-
 
| 2013 || || || Vaccine approval || The United States [[wikipedia:FDA|FDA]] approves influenza vaccine ''Flublok'' ([[wikipedia:Protein Sciences|Protein Sciences]]), developed through recombinant DNA technology.<ref>{{cite web|title=FDA Approves Flublok Quadrivalent Flu Vaccine|url=http://www.medscape.com/viewarticle/870201|website=medscape.com|accessdate=31 May 2018}}</ref> ||
 
| 2013 || || || Vaccine approval || The United States [[wikipedia:FDA|FDA]] approves influenza vaccine ''Flublok'' ([[wikipedia:Protein Sciences|Protein Sciences]]), developed through recombinant DNA technology.<ref>{{cite web|title=FDA Approves Flublok Quadrivalent Flu Vaccine|url=http://www.medscape.com/viewarticle/870201|website=medscape.com|accessdate=31 May 2018}}</ref> ||
 +
|-
 +
| 2013 || May 17 || {{w|Yellow fever}} || || "Booster dose of yellow fever vaccine not needed, according to WHO. A single dose of vaccine is effective in providing long-term protection from yellow fever."<ref>{{cite web |title=Yellow fever vaccination booster not needed |url=https://www.who.int/mediacentre/news/releases/2013/yellow_fever_20130517/en/ |website=who.int |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2013 || June 7 || {{w|Influenza}} || Vaccine approval || "FDA approved Fluzone (Sanofi Pasteur) as the third quadrivalent influenza vaccine licensed for U.S. use."<ref>{{cite web |title=MEMORANDUM |url=https://www.fda.gov/media/97324/download |website=fda.gov |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2014 || October 29 || Serogroup B meningococcal disease || Vaccine approval || "FDA approved the use of Trumenba in the U.S. to prevent serogroup B meningococcal disease."<ref>{{cite web |title=Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (CBER) Division of Epidemiology (DE) |url=https://www.fda.gov/media/111536/download |website=fda.gov |accessdate=3 June 2020}}</ref> ||
 +
|-
 +
| 2014 || December 10 || {{w|Human papillomavirus infection}} || Vaccine approval || "FDA approved the use of Gardasil 9 (Merck) 9-valent HPV vaccine in the U.S."<ref>{{cite web |title=Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices |url=https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm#:~:text=9vHPV%20was%20approved%20by%20the,through%2015%20years%20(3). |website=cdc.gov |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2014 || December 11 || {{w|Influenza}} || Vaccine approval || "FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine."<ref>{{cite web |title=Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season |url=https://www.aafp.org/dam/AAFP/documents/patient_care/influenza/influenza-policy.pdf |website=aafp.org |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2014 || December 19 || {{w|Influenza}} || Vaccine approval || "FDA approved Rapivab to treat influenza infection"<ref>{{cite book |last1=Kliegman |first1=Robert M. |last2=Stanton |first2=Bonita M.D. |last3=Geme |first3=Joseph St. |last4=Schor |first4=Nina F |title=Nelson Textbook of Pediatrics E-Book |url=https://books.google.com.ar/books?id=P9piCAAAQBAJ&pg=PA1602&lpg=PA1602&dq=December+19,+2014+FDA+approved+Rapivab+to+treat+influenza+infection&source=bl&ots=2fmyn4yp5E&sig=ACfU3U2XcEdP40sVfsPf_LDVPci9JOXl_A&hl=en&sa=X&ved=2ahUKEwituZmeleTpAhUGIbkGHR4TB9AQ6AEwA3oECAgQAQ#v=onepage&q=December%2019%2C%202014%20FDA%20approved%20Rapivab%20to%20treat%20influenza%20infection&f=false}}</ref> ||
 
|-
 
|-
 
| 2015 || || || Vaccine approval || The {{w|RTS,S/AS01}} (trade name Mosquirix) becomes the world's first licensed {{w|malaria vaccine}}. Approved for use by European regulators.<ref>{{cite web|title=Malaria vaccine gets 'green light'|url=http://www.bbc.com/news/health-33641939?ns_mchannel=social&ns_campaign=bbc_news&ns_source=google_plus&ns_linkname=news_central|website=bbc.com|accessdate=26 April 2018}}</ref> ||
 
| 2015 || || || Vaccine approval || The {{w|RTS,S/AS01}} (trade name Mosquirix) becomes the world's first licensed {{w|malaria vaccine}}. Approved for use by European regulators.<ref>{{cite web|title=Malaria vaccine gets 'green light'|url=http://www.bbc.com/news/health-33641939?ns_mchannel=social&ns_campaign=bbc_news&ns_source=google_plus&ns_linkname=news_central|website=bbc.com|accessdate=26 April 2018}}</ref> ||
 +
|-
 +
| 2015 || January 23 || Serogroup B meningococcal disease || Vaccine approval || " FDA approved the use of Bexsero, the second vaccine licensed in the U.S. to prevent serogroup B meningococcal disease."<ref>{{cite web |title=Bexsero: A Second Vaccine to Prevent Serogroup B Meningococcal Disease |url=https://www.jwatch.org/na36940/2015/02/04/bexsero-second-vaccine-prevent-serogroup-b-meningococcal |website=jwatch.org |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2015 || March 24 || || Vaccine approval || "FDA approved Quadracel, a new combination DTaP+IPV vaccine for use in children age 4–6 years."<ref>{{cite web |title=Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research |url=https://www.fda.gov/media/116073/download |website=fda.gov |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2015 || April 29 || {{w|Rubella}} || || "The Pan American Health Organization declared rubella eliminated in the Americas."<ref>{{cite web |title=Americas region is declared the world's first to eliminate rubella |url=https://www.paho.org/hq/index.php?option=com_content&view=article&id=10798:2015-americas-free-of-rubella&Itemid=1926&lang=en#:~:text=Washington%2C%20D.C.%2C%2029%20April%202015,contracted%20by%20women%20during%20pregnancy. |website=paho.org |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2015 || November 24 || Influenza || Vaccine approval || "FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older"<ref>{{cite web |title=FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant |url=https://community.aafa.org/blog/fda-approves-first-seasonal-influenza-vaccine-containing-an-adjuvant |website=community.aafa.org |accessdate=2 June 2020}}</ref> ||
 +
|-
 +
| 2016 || January 14 || Haemophilus influenzae || Vaccine approval || "FDA approved Hiberix for full Hib vaccine series."<ref>{{cite web |title=Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus Influenzae Type b (Hib) Vaccination Series |url=https://www.medscape.com/viewarticle/862684#:~:text=On%20January%2014%2C%202016%2C%20GlaxoSmithKline,%2C%204%2C%20and%206%20months. |website=medscape.com |accessdate=2 June 2020}}</ref> ||
 
|-
 
|-
 
| 2016 || || || Commercial launch || A partially effective {{w|dengue vaccine}} (Dengvaxia) becomes commercially available in 11 countries: Mexico, the Philippines, Indonesia, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Thailand, and Singapore.<ref name="reuters.com">{{cite web|title=Sanofi's dengue vaccine approved in 11 countries|url=https://www.reuters.com/article/us-sanofi-vacccine-idUSKCN1240C5|website=Reuters|accessdate=25 April 2018}}</ref><ref>{{cite news|last1=East|first1=Susie|title=World's first dengue fever vaccine launched in the Philippines|url=http://edition.cnn.com/2016/04/06/health/dengue-fever-vaccine-philippines/|accessdate=25 April 2018|publisher=CNN}}</ref> ||
 
| 2016 || || || Commercial launch || A partially effective {{w|dengue vaccine}} (Dengvaxia) becomes commercially available in 11 countries: Mexico, the Philippines, Indonesia, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Thailand, and Singapore.<ref name="reuters.com">{{cite web|title=Sanofi's dengue vaccine approved in 11 countries|url=https://www.reuters.com/article/us-sanofi-vacccine-idUSKCN1240C5|website=Reuters|accessdate=25 April 2018}}</ref><ref>{{cite news|last1=East|first1=Susie|title=World's first dengue fever vaccine launched in the Philippines|url=http://edition.cnn.com/2016/04/06/health/dengue-fever-vaccine-philippines/|accessdate=25 April 2018|publisher=CNN}}</ref> ||
 
|-
 
|-
 
| 2016 || || {{w|Diphtheria}} || Statistics || About 86% of the world population was vaccinated as of year.<ref name="auto">{{cite web|title=Diphtheria|url=http://www.who.int/immunization/monitoring_surveillance/burden/diphtheria/en/|website=[[World Health Organization]] (WHO)|accessdate=1 June 2020|date=3 September 2014|url-status=live}}</ref> || Worldwide
 
| 2016 || || {{w|Diphtheria}} || Statistics || About 86% of the world population was vaccinated as of year.<ref name="auto">{{cite web|title=Diphtheria|url=http://www.who.int/immunization/monitoring_surveillance/burden/diphtheria/en/|website=[[World Health Organization]] (WHO)|accessdate=1 June 2020|date=3 September 2014|url-status=live}}</ref> || Worldwide
 +
|-
 +
| 2016 || June 10 || {{w|Cholera}} || Vaccine approval || "FDA approved Vaxchora for the prevention of cholera."<ref>{{cite web |title=FDA Approves First Cholera Vaccine in the US |url=https://www.medscape.com/viewarticle/864673 |website=medscape.com |accessdate=2 June 2020}}</ref> ||
 
|-
 
|-
 
| 2016 || September 27 || {{w|Measles}} || || "PAHO/WHO announced measles elimination in the Americas."<ref>{{cite web |title=Region of the Americas is declared free of measles |url=https://www.paho.org/hq/index.php?option=com_content&view=article&id=12528:region-americas-declared-free-measles&Itemid=1926&lang=en#:~:text=Region%20of%20the%20Americas%20is%20declared%20free%20of%20measles,brain%20swelling%20and%20even%20death. |website=paho.org |accessdate=2 June 2020}}</ref> ||
 
| 2016 || September 27 || {{w|Measles}} || || "PAHO/WHO announced measles elimination in the Americas."<ref>{{cite web |title=Region of the Americas is declared free of measles |url=https://www.paho.org/hq/index.php?option=com_content&view=article&id=12528:region-americas-declared-free-measles&Itemid=1926&lang=en#:~:text=Region%20of%20the%20Americas%20is%20declared%20free%20of%20measles,brain%20swelling%20and%20even%20death. |website=paho.org |accessdate=2 June 2020}}</ref> ||

Latest revision as of 20:43, 30 June 2020

This is a timeline of vaccines , focusing especially on their release. One of the brightest chapters in the history of science is the impact of vaccines on human longevity and health.[1]

Big picture

Time period Development summary
Ancient times Inoculation against smallpox is practiced at least since the beginning of the Common era in China and India.
<18th century Variolation is likely practiced in Africa, India, and China.[2]
18th century The history of vaccines starts late in the century.[1] The first smallpox vaccine is achieved.
19th century Late in the century, vaccines start being developed in the laboratory.[1] Another important discovery is that immunogenicity can be retained if bacteria are carefully killed by heat or chemical treatment.[1]
20th century In the 20th century, it becomes possible to develop vaccines based on immunologic markers. Chemical inactivation is also applied to viruses, with the influenza vaccine becoming the first successful inactivated virus vaccine.[1]
1890–1950 Bacterial vaccine development proliferates, including the Bacillis-Calmette-Guerin (BCG) vaccination, which is still in use today.[3] By 1900, there are already two human virus vaccines, against smallpox and rabies, and three bacterial vaccines against typhoid, cholera, and plague.[4] By the end of the 1920s, vaccines for diphtheria, tetanus, whooping cough and tuberculosis are all available.[5] By the 1940s, virologists understand that attenuation can be achieved by passage in abnormal hosts.[1]
1950–1985 Viral tissue culture methods develop, leading to the advent of the Salk (inactivated) polio vaccine and the Sabin (live attenuated oral) polio vaccine.[3] Vaccine development starts being based on rational choices since the mid century, when immunology advances to the point of distinguishing protection mediated by antibody and that mediated by lymphocytes, and when passage in cell culture permits the selection of attenuated mutants.[1]
Late 1970s–1980s Period of increasing litigation and decreased profitability for vaccine manufacture, leading to a decline in the number of companies producing vaccines.[3]
21th century In the current century, molecular biology permits vaccine development that was not possible before.[1] Historically deemed to be “only for children”, vaccines for adults are becoming increasingly common and necessary.[6]

Recommended vaccines

Vaccines for children[6]

Time period Recommended vaccines Additions Removals
Late 1940s Smallpox, diphtheria, tetanus, pertussis Smallpox, diphtheria, tetanus, pertussis
Late 1950s Smallpox, diphtheria, tetanus, pertussis, polio (IPV) Polio (IPV)
Late 1960s Smallpox, diphtheria, tetanus, pertussis, polio (OPV), measles, mumps, rubella Measles, mumps, rubella Polio (IPV)
Late 1970s Diphtheria, tetanus, pertussis, polio (OPV), measles, mumps, rubella Smallpox
1985–1994 Diphtheria, tetanus, pertussis, measles, mumps, rubella, polio (OPV), Hib Hib
1994–1995 Diphtheria, tetanus, pertussis, measles, mumps, rubella, polio (OPV), Hib, hepatitis B Hepatitis B
2000 Diphtheria, tetanus, pertussis, measles, mumps, rubella, polio (IPV), Hib, hepatitis B, varicella, hepatitis A. varicella, hepatitis A, polio (IPV) Polio (OPV)
2005 Diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, Hib, hepatitis B, varicella, hepatitis A, pneumococcal, influenza. Pneumococcal, influenza
2010 Diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, Hib, hepatitis B, varicella, hepatitis A, pneumococcal, influenza, rotavirus Rotavirus

Vaccines for adolescents[6]

Time period Recommended Vaccines Catch-up Sub-groups
2000 Tetanus, Diphtheria (Td) vaccine MMR, hepatitis B, varicella hepatitis A
2005 Td MMR, hepatitis B, varicella hepatitis A, pneumococcus, influenza
2010 Tetanus, Diphtheria, and Pertussis (Tdap) vaccine, HPV, meningococcus, influenza MMR, hepatitis B, varicella, polio hepatitis A, pneumococcus

Full timeline

Year Month and date Disease Event type Details Country/location
1670 Immunization Circassian traders introduce variolation to the Ottoman Empire.[2]
1714 Immunization The Royal Society of London receives a letter from Emanuel Timoni describing the technique of variolation, which he witnessed in Istanbul.[2]
1721 Immunization The regular practice of variolation reaches the New World.[2]
1796 Vaccine English physician Edward Jenner tests vaccination inoculating a 13 year-old-boy with vaccinia virus (cowpox), and demonstrates immunity to smallpox.[7] Jenner is considered the founder of vaccinology in the Western World.[3]
1798 Vaccine The first smallpox vaccine is developed.[3]
1803 Organization The Royal Jennerian Society for the Extermination of the Smallpox founded in London.[5][8]
1877 Scientific development Louis Pasteur propounds germ theory of disease and develops techniques to create vaccines.[7][9]
1879 Vaccine Louis Pasteur creates the first live attenuated bacterial vaccine (chicken cholera).[9]
1884 Vaccine Louis Pasteur develops the first live attenuated viral vaccine (rabies), using dessicated brain tissue inactivated with formaldehyde.[9]
1885 Vaccine Louis Pasteur first uses the rabies vaccine in humans.[9]
1890 Vaccine German bacteriologist Emil von Behring, working in the laboratory of Robert Koch, discovers the tetanus vaccine.[10][5]
1896 Vaccine The typhoid fever vaccine is introduced.[11]
1897 Vaccine The plague vaccine is introduced by Russian bacteriologist Waldemar Haffkine.[9]
1901 Award Emil von Behring is awarded the first Nobel Prize for Physiology and Medicine, for his work on the development of a diphtheria antitoxin.
1907 Vaccine Several cities in Europe and the United States begin immunization programs to administer the toxin–antitoxin (TAT) complex against diphtheria.[12]
1921 Vaccine The tuberculosis vaccine is first used in humans, offering only hit-or-miss protection, ranging from 14 percent to 80 percent effectiveness in preventing tuberculosis.[13]
1923 Vaccine French veterinarian Gaston Ramon, at the Pasteur Institute in France, develops the diphtheria toxoid vaccine.[14]
1923 Scientific development British immunologist Alexander Glenny perfects a method to inactivate tetanus toxin with formaldehyde.[3]
1926 Vaccine The whole cell killed pertussis vaccine becomes available.[15]
1929 Scientific development The utility of protein conjugation of polysaccharides is shown by Avery and Goebel. This discovery would prove useful later when Schneerson, Robbins, and coworkers make a conjugated Haemophilus influenzae type b vaccine.[1]
1932 Vaccine Andrew Sellards, from Harvard University, and Jean Laigret, from the Pasteur Institute, develop the so called French vaccine against yellow fever.[16]
1936 Vaccine South African virologist Max Theiler develops his vaccine against yellow fever.[17]
1937 Vaccine Tetanus toxoid is first licensed as a vaccine.[18]
1938 Vaccine Herld Cox develops the first successful typhus vaccine, using the yolk sac of the chick embryo to grow Rickettsia rickettsii.[19]
1941 Vaccine The first vaccine against tick-borne encephalitis is prepared in the brains of mice.[20]
1942 Vaccine Bivalent vaccine is produced after the discovery of influenza B.[21]
1945 Vaccine The first influenza vaccine is approved for military use in the United States.[22]
1948 Vaccine A whole cell vaccine against pertussis is first licensed for use in the United States.[3]
1948 Vaccine An inactivated mumps vaccine is developed. However, this vaccine would produce only short-lasting immunity.[23]
1951 Award Max Theiler is awarded the Nobel Prize in Physiology or Medicine for developing a vaccine against yellow fever.
1953 (March 26) Vaccine American medical researcher Jonas Salk announces on a national radio show that he has successfully tested a vaccine against poliomyelitis.[24]
1954 Vaccine A mouse brain derived inactivated Japanese encephalitis vaccine is first licensed in Japan.[25]
1954 Vaccine The first anthrax vaccine is developed, derived from an alum-precipitated cell-free filtrate of an aerobic culture of B antliracis.[26]
1956 Program The World Health Organization (WHO) decides to try to eradicate smallpox across the world. This is the first attempt to use the smallpox vaccine on a global scale.[5]
1957 Vaccine The first adenovirus vaccine is commercially available. It is used primarily in the United States military.[27]
1962 Vaccine Albert Sabin develops an oral polio vaccine that cost less, is easier to administer, and reduces the multiplication of the virus in the intestine.[28]
1963 Vaccine The measles vaccine is first introduced.[29]
1963 Organization The Joint Committee on Vaccination and Immunisation (JCVI) is established as an independent expert advisory committee.[30]
1964 Publication World Health Organization recommendations for the production and quality control of diphtheria vaccines are first formulated.[31]
1965 Program United States President Lyndon B Johnson establishes the CDC Smallpox Eradication program, establishing a legacy of US leadership in global immunization.[17]
1968 Vaccine American microbiologist Maurice Hilleman develops a weak measles vaccine. This vaccine is estimated to prevent 1 million deaths worldwide every year.[32][33]
1969 Vaccine The first rubella vaccines are licensed.[34]
1971 Vaccine The Measles-mumps-rubella (MMR) vaccine is introduced, resulting from the combination of the three vaccines (for mumps , measles, and rubella).[35]
1973 Program The World Health Organization starts issuing annual recommendations for the composition of the influenza vaccine based on results from surveillance systems that would identify currently circulating strains.[21]
1974 Program The World Health Organization launches the Expanded Program on Immunization (EPI), with the initial goals to ensure that every child receive protection against six childhood diseases (i.e. tuberculosis, polio, diphtheria, pertussis, tetanus and measles) by the time they were one year of age, and to give tetanus toxoid vaccinations to women to protect them and their newborns against tetanus.[4]
1977 Vaccine The first pneumococcal vaccine is licensed in the United States.[36]
1978 Vaccine The United States become the first to license a vaccine to help protect against 4 of the 5 major serogroups of meningococcal bacteria.[37]
1978 Vaccine The first trivalent influenza vaccine is introduced. It includes two influenza A strains and one influenza B strain.[21]
1979 Eradication The World Health Assembly officially declares smallpox eradicated.[4][5]
1980 Vaccine United States FDA approves influenza vaccine Fluzone (Sanofi Pasteur), developed for A subtype viruses and type B virus contained in the vaccine.[38]
1981 Vaccine The first hepatitis B vaccine is approved in the United States.[39]
1984 Vaccine A varicella vaccine is first licensed in several countries in Europe.[40]
1985 Vaccine The first vaccine to protect against Hib diseases is introduced in the United States.[41]
1985 Program Rotary Club International launches PolioPlus, a campaign with the purpose of getting rid the world of poliomielitis. Since then, the organization and its partners would help reduce the number of cases from 350,000 annually to fewer than 400 in 2014, remaining committed until the disease is eradicated.[42]
1987 Vaccine The hepatitis B Vax II (recombinant) vaccine is introduced.[43]
1989 Vaccine Q-Vax is licensed in Australia, for Q fever.[44]
1989 Vaccine Hepatitis B vaccine, Engerix-B, is approved.[17]
1990 Coverage By this time, vaccination protects over 80% of the world's children from the six main EPI diseases (tuberculosis, polio, diphtheria, pertussis, tetanus and measles), and other new vaccines are continually being added to the EPI programmes in many countries.[4]
1990 Vaccine Ipol, an enhanced-potency inactivated poliovirus vaccine, by Pasteur Méérieux Vaccins et Serums, is licensed.[45]
1991 Vaccine The world's first hepatitis A vacine is approved in Switzerland and Belgium.[46]
1991 Organization Every Child By Two is founded in the United States as a non-profit health advocacy organization, which advocates for vaccinations.[47]
1993 Organization The Sabin Vaccine Institute is founded in the United States as a non-profit organization promoting global vaccine development, availability, and use.[48]
1996 Diphtheria, tetanus, pertussis, hepatitis B.[49] A branded formulation of the DTP-HepB vaccine, Tritanrix-HepB manufactured by GlaxoSmithKline, is granted marketing approval in the United States.[50] United States
1997 Organization The International Vaccine Institute (IVI) is founded as an international nonprofit organization on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. IVI is involved in all areas of the vaccine spectrum, working in collaboration with the international scientific community, public health organizations, governments, and industry.[51]
1998 Vaccine The United States Food and Drug Administration approves Lymerix, the world's first Lyme vaccine.[52]
1998 Vaccine The first rotavirus vaccine, RotaShield, is licensed and recommended for routine childhood immunization. However, it would be witdrawn in 1999 due to safety concerns.[53]
1999 Organization The Global Alliance for Vaccines and Immunization (GAVI) is created to extend the reach of the Expanded Program on Immunization and to help the poorest countries introduce new and under-used life-saving vaccines into their national programs.[4]
2000 Organization The Brighton Collaboration launches as an international volun­ta­ry collaboration of scientific experts, launched. It facilitates the development, evaluation and dissemination of high-quality information about the safety of human vaccines.[54]
2000 Organization Gavi, the Vaccine Alliance launches as a public–private global health partnership committed to increasing access to immunization in poor countries.[55]
2001 Program The Meningitis Vaccine Project launches with the task to develop, test, license, and introduce a group A meningococcal (MenA) conjugate vaccine for sub-Saharan Africa.[56]
2003 Vaccine The United States FDA first licenses FluMist –an intranasally administered influenza vaccine, for healthy, nonpregnant persons aged 5–49 years.[57]
2004 Vaccine Flumist is approved as an intranasal flu vaccine.[17]
2006 Vaccine A new rotavirus vaccine becomes available.[53]
2006 Vaccine A shingles vaccine is first licensed under generic name Zoster Vaccine (tradename Zostavax).[58]
2006 Organization The Collaboration for AIDS Vaccine Discovery is founded when the Bill & Melinda Gates Foundation donates US$287 million to promote HIV vaccine research. The organization is an international network of scientists, research organizations, and promoters of HIV vaccine research.[59]
2006 Organization The Global action plan for influenza vaccines is launched as a 10-year initiative by the World Health Organization, with the purpose to reduce the global shortage and inequitable access to influenza vaccines in the event of an influenza pandemic.[60][61]
2007 (February 9) Program Five countries (Canada, Italy, Norway, Russia, the United Kingdom), and the Bill & Melinda Gates Foundation commit US$1.5 billion to launch the first Advance Market Commitment (AMC) with the purpose of accelerating access to vaccines against pneumococcal disease.[62]
2007 (September 1) "On September 1, 2007, the U.S. Food and Drug Administration (FDA) licensed a new vaccine ACAM2000 against smallpox which can be produced quickly upon need. Manufactured by Sanofi Pasteur, the U.S. Centers for Disease Control and Prevention stockpiled 192.5 million doses of the new vaccine (see list of common strains below).[63]" United States
2009 September 15 Influenza Vaccine approval The United States FDA approves four vaccines against the Influenza A virus subtype H1N1.[64][65]
2009 October 16 "FDA approved new indication for gardasil to prevent genital warts in men and boys."[66]
2009 October 16 Vaccine The United States FDA approves Cervarix, by GlaxoSmithKline, for the prevention of cervical cancer.[9]
2009 General Research The journal Pediatrics concludes that the largest risk among unvaccinated children is not the contraction of side effects, but rather the disease that the vaccination aims to protect against.[67]
2009 December 23 "FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years and older."[68]
2010 January 29 "January 29, 2010 WHO hailed new Gates Foundation support ($10 billion) as the "Decade of Vaccines.""[69]
2010 February 19 Vaccine approval "FDA approved licensure of Menveo (Novartis), meningococcal conjugate vaccine for people ages 11 through 55 years."[70]
2010 February 24 Streptococcus pneumoniae " FDA approved licensure of Pneumococcal 13-valent conjugate vaccine (PCV13), which offers broader protections against Steptococcus pneumoniae infections."[71][72]
2010 July Smallpox "First smallpox vaccine for certain immune-compromised populations delivered under Project BioShield."[73]
2010 December 22 Human papillomavirus infection "FDA approved Gardasil HPV vaccine to include the indication for the prevention of anal cancer."[74]
2011 April 22 Meningococcal disease Vaccine approval "FDA approved the first vaccine (Menactra, meningococcal conjugate vaccine, Sanofi Pasteur) to prevent meningococcal disease in infants and toddlers."[75]
2011 July 8 "FDA approved Boostrix (Tdap, GlaxoSmithKline) to prevent tetanus, diphtheria, and pertussis in older people."[76]
2012 June 5 "U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) released a report titled "Vaccines for Children (VFC) Program: Vulnerabilities in Vaccine Management."[77]
2012 June Meningococcal disease Vaccine approval "FDA approved HibMenCY (Menhibrix, GlaxoSmithKline), a new combination (meningococcal and Hib) vaccine for infants."[78]
2012 April 1 "United Nations Foundation launched Shot@Life campaign."[79]
2012 Vaccine approval A quadrivalent inactivated influenza vaccine is licensed in the United States.[80]
2012 November 20 Influenza Vaccine approval "FDA approved first seasonal influenza vaccine manufactured using cell culture technology (Flucelvax, Novartis)."[81]
2012 December 12 Influenza Vaccine approval "FDA approved quadrivalent formulation of Fluarix (inactivated influenza vaccine; GlaxoSmithKline)."[82]
2012 December 12 "On December 11, 2012, the Institute for Safe Medication Practices (ISMP) issued a press release announcing the launch of its new Vaccine Error Reporting Program. The program allows healthcare professionals to confidentially report vaccine administration errors and near misses. According to the press release, the program's goal is to better quantify sources of errors and advocate for product changes (such as changes to the vaccine name or label) that will ensure patient safety."[83]
2013 January 25 Pneumococcal disease Vaccine approval "FDA approved use of Prevnar 13 vaccine in older children and teens (6-17 years)."[84]
2013 February 22 Tetanus, diphtheria, pertussis Recommendation "ACIP recommended a dose of Tdap vaccine during each pregnancy."[85]
2013 Vaccine approval The United States FDA approves influenza vaccine Flublok (Protein Sciences), developed through recombinant DNA technology.[86]
2013 May 17 Yellow fever "Booster dose of yellow fever vaccine not needed, according to WHO. A single dose of vaccine is effective in providing long-term protection from yellow fever."[87]
2013 June 7 Influenza Vaccine approval "FDA approved Fluzone (Sanofi Pasteur) as the third quadrivalent influenza vaccine licensed for U.S. use."[88]
2014 October 29 Serogroup B meningococcal disease Vaccine approval "FDA approved the use of Trumenba in the U.S. to prevent serogroup B meningococcal disease."[89]
2014 December 10 Human papillomavirus infection Vaccine approval "FDA approved the use of Gardasil 9 (Merck) 9-valent HPV vaccine in the U.S."[90]
2014 December 11 Influenza Vaccine approval "FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine."[91]
2014 December 19 Influenza Vaccine approval "FDA approved Rapivab to treat influenza infection"[92]
2015 Vaccine approval The RTS,S/AS01 (trade name Mosquirix) becomes the world's first licensed malaria vaccine. Approved for use by European regulators.[93]
2015 January 23 Serogroup B meningococcal disease Vaccine approval " FDA approved the use of Bexsero, the second vaccine licensed in the U.S. to prevent serogroup B meningococcal disease."[94]
2015 March 24 Vaccine approval "FDA approved Quadracel, a new combination DTaP+IPV vaccine for use in children age 4–6 years."[95]
2015 April 29 Rubella "The Pan American Health Organization declared rubella eliminated in the Americas."[96]
2015 November 24 Influenza Vaccine approval "FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older"[97]
2016 January 14 Haemophilus influenzae Vaccine approval "FDA approved Hiberix for full Hib vaccine series."[98]
2016 Commercial launch A partially effective dengue vaccine (Dengvaxia) becomes commercially available in 11 countries: Mexico, the Philippines, Indonesia, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Thailand, and Singapore.[99][100]
2016 Diphtheria Statistics About 86% of the world population was vaccinated as of year.[101] Worldwide
2016 June 10 Cholera Vaccine approval "FDA approved Vaxchora for the prevention of cholera."[102]
2016 September 27 Measles "PAHO/WHO announced measles elimination in the Americas."[103]
2016 November 18 Influenza Vaccine approval "FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age."[104]
2016 (December) Study A study finds the rVSV-ZEBOV vaccine against Ebola virus disease to be 95-100% effective, making it the first proven vaccine against the disease.[105][106]
2017 April 20 Recommendation "CDC published ACIP recommendations titled "General Best Practice Guidelines for Immunization" to replace the 2011 "General Recommendations on Immunization."[107]
2017 August Hepatitis B Policy "AAP issued policy stating that newborns should routinely receive hepatitis B vaccine within 24 hours of birth."[108]
2017 August 25 Influenza Recommendation "CDC published ACIP 2017–18 influenza vaccination recommendations."[109]
2017 August 31 Influenza Vaccine approval "FDA expanded licensure of Afluria quadrivalent (Seqirus) to include people age 5 years and older."[110]
2017 September 15 Hepatitis A "CDC published updated dosing instructions for hepatitis A prophylaxis with immune globulin."[111] United States
2017 October 20 Shingles Vaccine approval "FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older."[112]
2017 November 9 Hepatitis B Vaccine approval "FDA licensed Heplisav-B, the new hepatitis B vaccine from Dynavax, for use in adults age 18 and older."[113] United States
2018 January 11 Influenza Vaccine approval "FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine."[114] United States
2018 January 12 Hepatitis B Recommendation "CDC published updated ACIP recommendations for prevention of hepatitis B virus infection."[115]
2018 January 26 Herpes zoster Recommendation "CDC published ACIP recommendations for use of herpes zoster vaccines."[116]
2018 April 20 Hepatitis B Recommendation "CDC published ACIP recommendations for use of hepatitis B vaccine with a novel adjuvant [Heplisav-B]."[117]
2018 June 8 Influenza Recommendation "CDC published ACIP's recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) in the 2018–19 influenza season."[118]
2018 August 24 Influenza Recommendation "CDC published ACIP's 2018–19 influenza vaccination recommendations."[119]
2018 October 5 Human papillomavirus infection Vaccine approval "FDA announced approval of expanded use of Merck’s Gardasil 9 (HPV9, Human papillomavirus) vaccine to include adults 27 through 45 years old."[120]
2018 October Influenza Vaccine approval "FDA approved expanded age indication for Seqirus’s Afluria influenza vaccine to include children age 6 months through 59 months."[121]
2018 October 25 Human papillomavirus infection Recommendation "The American Dental Association adopted a policy to support the use and administration of HPV vaccine for the prevention of oral HPV infection."[122] United States
2018 November 7 Hepatitis A Recommendation " The Advisory Committee on Immunization Practices (ACIP) published updated recommendations on use of hepatitis A vaccine for pre- and post-exposure prophylaxis for international travel."[123]
2018 December 21 Diphtheria, tetanus, pertussis, polio, haemophilus influenzae type b (Hib), hepatitis B Vaccine approval "FDA approved Vaxelis (MCM Vaccine Co), a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks–4 yrs of age."[124] United States
2019 January 14 Tetanus, diphtheria, pertussis Vaccine approval "FDA approved expanded use of Sanofi's Adacel Tdap vaccine for a second dose in people ages 10 through 64 years of age."[125]
2019 January 23 Influenza Vaccine approval "FDA approved use of the 0.5 mL dose of Sanofi's Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months."[126] United States
2019 February 5 "CDC released the 2019 U.S. recommended immunization schedules for children/adolescents as well as for adults on its website."[127]
2019 February 15 Hepatitis A Recommendation "CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness."[128]
2019 July 19 Japanese encephalitis Recommendation "CDC published ACIP recommendations on use of Japanese encephalitis vaccine"[129]
2019 August 1 Recommendation "AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC released "Dear Colleague" letter stressing importance of 16-year-old immunization visit."[130]
2019 August 16 Papillomavirus Recommendation "August 16, 2019 CDC published updated ACIP recommendations for human papillomavirus vaccination of adults."[131] United States
2019 August 28 Influenza Recommendation "CDC released ACIP recommendations on the use of influenza vaccines for the 2019–20 influenza season."[132] United States
2019 November 4 Influenza Vaccine approval "FDA approved Fluzone High-Dose Quadrivalent (Sanofi Pasteur) for adults 65+ years of age—will be available for 2020–21 flu season."[133] United States
2019 November 22 Pneumococcal disease Recommendation "CDC published updated ACIP recommendations for the use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older."[134] United States
2019 December 13 Anthrax Recommendation "CDC published ACIP recommendations on the use of BioThrax (anthrax vaccine, adsorbed; Emergent BioSolutions)" [135] United States
2019 December 19 Ebola Vaccine approval "First FDA-approved vaccine for the prevention of Ebola virus"[136] United States
2020 January 24 Diphtheria, tetanus, pertussis Recommendation "CDC published updated ACIP recommendations on the use of Td and Tdap vaccines."[137] United States
2020 January 30 Background CDC declares public health emergency regarding 2019 novel coronavirus. United States
2020 February 1 Background WHO declares public health emergency regarding 2019 novel coronavirus.
2020 February 3 Recommendation The CDC website releases the 2020 recommended immunization schedules for children and adolescents, as well as for adults.[138] United States
2020 February 21 Influenza Vaccine approval "FDA Approves 1st Adjuvanted Quadrivalent Flu Shot For Seniors"[139] United States

Meta information on the timeline

How the timeline was built

The initial version of the timeline was written by User:Sebastian.

Funding information for this timeline is available.

Feedback and comments

Feedback for the timeline can be provided at the following places:

  • FIXME

What the timeline is still missing

Timeline update strategy

See also

External links

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 "History of vaccination". pnas.org. Retrieved 8 May 2018. 
  2. 2.0 2.1 2.2 2.3 Riedel, Stefan. "Edward Jenner and the history of smallpox and vaccination". PMID 16200144. 
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 "A brief history of vaccination". immune.org.nz. Retrieved 22 April 2018. 
  4. 4.0 4.1 4.2 4.3 4.4 "HISTORY OF VACCINE DEVELOPMENT". vaccine-safety-training.org. Retrieved 26 April 2018. 
  5. 5.0 5.1 5.2 5.3 5.4 "The history of vaccination". nhs.uk. Retrieved 29 April 2018. 
  6. 6.0 6.1 6.2 "Vaccine History: Developments by Year". chop.edu. Retrieved 7 May 2018. 
  7. 7.0 7.1 Yount, Lisa. A to Z of Biologists. 
  8. "Royal Jennerian Society for the Extermination of the Small-pox". collections.countway.harvard.edu. Retrieved 29 April 2018. 
  9. 9.0 9.1 9.2 9.3 9.4 9.5 "Vaccine Timeline". immunize.org. Retrieved 24 April 2018. 
  10. Newton, David E. Sick! Diseases and Disorders, Injuries and Infections, Volume 4. 
  11. Riley, James C. Low Income, Social Growth, and Good Health: A History of Twelve Countries. 
  12. "State of the world's vaccines and immunization" (PDF). who.int. Retrieved 31 May 2018. 
  13. Davis, Alison. Always There: The Remarkable Life of Ruth Lillian Kirschstein, M.D. 
  14. Thomaz Soccol,, Vanete; Pandey, Ashok; Resende, Rodrigo R. Current Developments in Biotechnology and Bioengineering: Human and Animal Health Applications. 
  15. Halloran, M. Elizabeth; Longini, Ira M.; Struchiner, Claudio J. Design and Analysis of Vaccine Studies. 
  16. de Menezes Martins, Reinaldo; Fernandes Leal, Maria da Luz; Homma, Akira. Serious adverse events associated with yellow fever vaccine. doi:10.1080/21645515.2015.1022700. 
  17. 17.0 17.1 17.2 17.3 "Vaccine Timeline and History of Vaccines". vaxopedia.org. Retrieved 26 April 2018. 
  18. "Tetanus disease and deaths in men reveal need for vaccination". US National Library of Medicine. doi:10.2471/BLT.15.166777. 
  19. Plotkin, Stanley A.; Orenstein, Walter; Offit, Paul A.; Edwards, Kathryn M. Vaccines E-Book. 
  20. "Tick-borne Encephalitis Vaccine". who.int. Retrieved 24 April 2018. 
  21. 21.0 21.1 21.2 "The Evolving History of Influenza Viruses and Influenza Vaccines 1". medscape.com. Retrieved 31 May 2018. 
  22. "Influenza". historyofvaccines.org. Retrieved 24 April 2018. 
  23. "Mumps". cdc.gov. Retrieved 25 April 2018. 
  24. "This Week In History: March 26 – April 1". thegreatcoursesdaily.com. Retrieved 26 April 2018. 
  25. "Recommendations for Japanese encephalitis vaccine" (PDF). who.int. Retrieved 24 April 2018. 
  26. Medical Aspects of Biological Warfare. 
  27. Galasso, George J.; Whitley, Richard J.; Merigan, Thomas C. Antiviral Agents and Human Viral Diseases. 
  28. Skolnik. Global Health 101. 
  29. CDC Health Information for International Travel 2014: The Yellow Book. Centers for Disease Control and Prevention. 
  30. "Development Of Immunization Policy And Its Implementation In The United Kingdom". healthaffairs.org. Retrieved 1 June 2018. 
  31. "Diphtheria". who.int. Retrieved 31 May 2018. 
  32. "Measles History". Measles History. Centers for Disease Control and Prevention. Retrieved 31 May 2018. 
  33. "Maurice R. Hilleman Dies; Created Vaccines". The Washington Post. Retrieved 31 May 2018. 
  34. "Rubella". cdc.gov. Retrieved 25 April 2018. 
  35. "Measles: Questions and Answers" (PDF). immunize.org. Retrieved 25 April 2018. 
  36. "Pneumococcal Disease". cdc.gov. Retrieved 26 April 2018. 
  37. "Class is in Session, it's time for a Meningitis History Lesson". availclinical.com. Retrieved 25 April 2018. 
  38. "Fluzone". vaccineshoppe.com. Retrieved 31 May 2018. 
  39. "The Rationale for Developing a More Immunogenic Hepatitis B Vaccine". vbivaccines.com. Retrieved 26 April 2018. 
  40. "Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". cdc.gov. Retrieved 26 April 2018. 
  41. "Haemophilus influenzae type b (Hib)". historyofvaccines.org. Retrieved 25 April 2018. 
  42. "Historic Moments: PolioPlus turns 30". rotary.org. Retrieved 1 June 2018. 
  43. "Vaccine history timeline". health.vic.gov.au. Retrieved 25 April 2018. 
  44. Bewley, Kevin R. "Animal Models of Q Fever (Coxiella burnetii)". PMC 3866982Freely accessible. PMID 24326221. 
  45. "Vaccine Timeline". immunize.org. Retrieved May 31 2018.  Check date values in: |access-date= (help)
  46. The Children's Vaccine Initiative: Achieving the Vision. Institute of Medicine, Committee on the Children's Vaccine Initiative: Planning Alternative Strategies. 
  47. "About Us". ecbt.org. Retrieved 1 June 2018. 
  48. "Polioforever's Blog". polioforever.wordpress.com. Retrieved 1 June 2018. 
  49. Organization, World Health; Biologicals, World Health Organization Department of Immunization, Vaccines and (2004). Immunization in Practice: A Practical Guide for Health Staff. World Health Organization. p. 18. ISBN 9789241546515. Retrieved 15 July 2018. 
  50. "Tritanrix HepB". European Medicines Agency. Retrieved 14 July 2018. 
  51. "International Vaccine Institute (IVI)". devex.com. Retrieved 1 June 2018. 
  52. "Lyme Vaccine Pulled Off Market". lymepa.org. Retrieved 26 April 2018. 
  53. 53.0 53.1 "Rotavirus". historyofvaccines.org. Retrieved 25 April 2018. 
  54. "BRIGHTON COLLABORATION – SETTING STANDARDS IN VACCINE SAFETY". vaccine-safety-training.org. Retrieved 1 June 2018. 
  55. "Gavi - About". gavi.org. Retrieved 31 May 2018. 
  56. Tiffay, Kathleen; Jodar, Luis; Kieny, Marie-Paule; Socquet, Muriel; LaForce, F. Marc. "The Evolution of the Meningitis Vaccine Project". PMC 4639496Freely accessible. PMID 26553666. doi:10.1093/cid/civ594. Retrieved 1 June 2018. 
  57. "Notice to Readers: Expansion of Use of Live Attenuated Influenza Vaccine (FluMist®) to Children Aged 2--4 Years and Other FluMist Changes for the 2007--08 Influenza Season". cdc.gov. Retrieved 26 April 2018. 
  58. "Shingles (Herpes Zoster)". historyofvaccines.org. Retrieved 25 April 2018. 
  59. "Gates Foundation Funds Major New Collaboration to Accelerate HIV Vaccine Development - DukeHealth.org". dukehealth.org. 19 July 2006. Retrieved 31 May 2018. 
  60. "4th International Conference on Influenza and Zoonotic Diseases". influenza.infectiousconferences.com. Retrieved 30 June 2020. 
  61. "3rd WHO Consultation on Global Action Plan for Influenza Vaccines, November 2016". who.int. Retrieved 30 June 2020. 
  62. "GAVI partners fulfill promise to fight pneumococcal disease". gavi.org. Retrieved 1 June 2018. 
  63. Heilprin, John (1 September 2007). "FDA approves new smallpox vaccine". Houston Chronicle. AP. Retrieved 25 May 2018. 
  64. "FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine". gsk.com. Retrieved 3 June 2020. 
  65. "Update on Influenza A (H1N1) 2009 Monovalent Vaccines". cdc.gov. Retrieved 3 June 2020. 
  66. "FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys". natap.org. Retrieved 3 June 2020. 
  67. "Is Vaccine Refusal Worth The Risk?". NPR. 2009-05-26. Retrieved 1 June 2020. 
  68. "Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use --- United States, 2010". cdc.gov. Retrieved 3 June 2020. 
  69. "WHO hails new Gates Foundation support for decade of vaccines". who.int. Retrieved 3 June 2020. 
  70. Morbidity and Mortality Weekly Report: MMWR. 
  71. "Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)". cdc.gov. Retrieved 3 June 2020. 
  72. "Advisory No. 15. The New PCV13 Vaccine". dshs.state.tx.us. Retrieved 3 June 2020. 
  73. "First Smallpox Vaccine for Special Populations Delivered Under Project BioShield". infectioncontroltoday.com. Retrieved 3 June 2020. 
  74. "FDA: Gardasil Approved to Prevent Anal Cancer". prnewswire.com. Retrieved 3 June 2020. 
  75. "Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants". eurekalert.org. Retrieved 3 June 2020. 
  76. "FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine". Centers for Disease Control and Prevention. PMID 21937974. 
  77. "VACCINES FOR CHILDREN PROGRAM: VULNERABILITIES IN VACCINE MANAGEMENT" (PDF). oig.hhs.gov. Retrieved 3 June 2020. 
  78. Bennett, John E.; Dolin, Raphael; Blaser, Martin J. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book. 
  79. "Case Study: The UN Foundation's Shot@Life Campaign Mobilizes U.S. Moms to Fight Vaccine-Preventable Childhood Diseases". prnewsonline.com. Retrieved 3 June 2020. 
  80. "Influenza". historyofvaccines.org. Retrieved 26 April 2018. 
  81. "A First – Cell Culture Based Seasonal Influenza Vaccine Approved by the FDA". cellculturedish.com. Retrieved 3 June 2020. 
  82. "Quadrivalent flu vaccines coming; companies cite good demand". cidrap.umn.edu. Retrieved 3 June 2020. 
  83. "Issue 1033: January 2, 2013". immunize.org. Retrieved 3 June 2020. 
  84. "PFIZER RECEIVES FDA APPROVAL FOR THE USE OF PREVNAR 13 IN VACCINE-NAIVE CHILDREN AND ADOLESCENTS AGED 6 YEARS THROUGH 17 YEARS FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE". pfizer.com. Retrieved 3 June 2020. 
  85. "Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012". cdc.gov. Retrieved 3 June 2020. 
  86. "FDA Approves Flublok Quadrivalent Flu Vaccine". medscape.com. Retrieved 31 May 2018. 
  87. "Yellow fever vaccination booster not needed". who.int. Retrieved 3 June 2020. 
  88. "MEMORANDUM". fda.gov. Retrieved 3 June 2020. 
  89. "Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (CBER) Division of Epidemiology (DE)". fda.gov. Retrieved 3 June 2020. 
  90. "Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices". cdc.gov. Retrieved 2 June 2020. 
  91. "Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season" (PDF). aafp.org. Retrieved 2 June 2020. 
  92. Kliegman, Robert M.; Stanton, Bonita M.D.; Geme, Joseph St.; Schor, Nina F. Nelson Textbook of Pediatrics E-Book. 
  93. "Malaria vaccine gets 'green light'". bbc.com. Retrieved 26 April 2018. 
  94. "Bexsero: A Second Vaccine to Prevent Serogroup B Meningococcal Disease". jwatch.org. Retrieved 2 June 2020. 
  95. "Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research". fda.gov. Retrieved 2 June 2020. 
  96. "Americas region is declared the world's first to eliminate rubella". paho.org. Retrieved 2 June 2020. 
  97. "FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant". community.aafa.org. Retrieved 2 June 2020. 
  98. "Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus Influenzae Type b (Hib) Vaccination Series". medscape.com. Retrieved 2 June 2020. 
  99. "Sanofi's dengue vaccine approved in 11 countries". Reuters. Retrieved 25 April 2018. 
  100. East, Susie. "World's first dengue fever vaccine launched in the Philippines". CNN. Retrieved 25 April 2018. 
  101. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  102. "FDA Approves First Cholera Vaccine in the US". medscape.com. Retrieved 2 June 2020. 
  103. "Region of the Americas is declared free of measles". paho.org. Retrieved 2 June 2020. 
  104. "GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older". gsk.com. Retrieved 2 June 2020. 
  105. Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, et al. (2017). "Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)". Lancet. 389 (10068): 505–518. PMC 5364328Freely accessible. PMID 28017403. doi:10.1016/S0140-6736(16)32621-6. 
  106. Berlinger, Joshua (22 December 2016). "Ebola vaccine gives 100% protection, study finds". CNN. Retrieved 25 April 2018. 
  107. "Issue 1302: April 26, 2017". immunize.org. Retrieved 2 June 2020. 
  108. "Give first dose of HepB vaccine within 24 hours of birth: AAP". aappublications.org. Retrieved 2 June 2020. 
  109. Grohskopf, Lisa A.; Sokolow, Leslie Z.; Broder, Karen R.; Walter, Emmanuel B.; Bresee, Joseph S.; Fry, Alicia M.; Jernigan, Daniel B. "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season". cdc.gov. Retrieved 2 June 2020. 
  110. "BLA Clinical Review Memorandum". fda.gov. Retrieved 2 June 2020. 
  111. Nelson, Noele P. "Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis". cdc.gov. Retrieved 2 June 2020. 
  112. "BLA APPROVAL". fda.gov. Retrieved 2 June 2020. 
  113. "Summary Basis for Regulatory Action". fda.gov. Retrieved 2 June 2020. 
  114. "Summary Basis of Regulatory Action". fda.gov. Retrieved 2 June 2020. 
  115. Schillie, Sarah; Vellozzi, Claudia; Reingold, Arthur; Harris, Aaron; Haber, Penina; Ward, John W.; Nelson, Noele P. "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices". cdc.gov. Retrieved 2 June 2020. 
  116. Dooling, Kathleen L.; Guo, Angela; Patel, Manisha; Lee, Grace M.; Moore, Kelly; Belongia, Edward A.; Harpaz, Rafael. "Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines". cdc.gov. Retrieved 1 June 2020. 
  117. Schillie, Sarah; Harris, Aaron; Link-Gelles, Ruth; Romero, José; Ward, John; Nelson, Noele. "Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant". cdc.gov. Retrieved 1 June 2020. 
  118. Grohskopf, Lisa A.; Sokolow, Leslie Z.; Fry, Alicia M.; Walter, Emmanuel B.; Jernigan, Daniel B. "Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season". cdc.gov. Retrieved 1 June 2020. 
  119. "ACIP Influenza Vaccine Recommendations". cdc.gov. Retrieved 1 June 2020.  Text " CDC " ignored (help)
  120. "FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". fda.gov. Retrieved 1 June 2020. 
  121. Grohskopf, Lisa A.; Alyanak, Elif; Broder, Karen R.; Walter, Emmanuel B.; Fry, Alicia M.; Jernigan, Daniel B. "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season". cdc.gov. Retrieved 1 June 2020. 
  122. "ADA Adopts Policy on HPV Vaccination for the Prevention of Oral HPV Infection". ada.org. Retrieved 1 June 2020. 
  123. "Issue 1393: November 7, 2018". immunize.org. Retrieved 1 June 2020. 
  124. "Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants". medscape.com. Retrieved 1 June 2020. 
  125. "FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination". news.sanofi.us. Retrieved 1 June 2020. 
  126. "FDA approves use of 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) in children as young as 6 months of age". news.sanofi.us. Retrieved 1 June 2020. 
  127. "Immunization schedules updated for 2019". aappublications.org. Retrieved 1 June 2020. 
  128. Doshani, Mona; Weng, Mark; Moore, Kelly L.; Romero, José R.; Nelson, Noele P. "Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness". cdc.gov. Retrieved 1 June 2020. 
  129. "Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices". cdc.gov. Retrieved 1 June 2020. 
  130. ""Dear Colleague" Call-to-Action Letter from AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC Stresses Importance of Implementing Immunization Visit at 16 Years of Age". immunize.org. Retrieved 1 June 2020. 
  131. "Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices" (PDF). cdc.gov. Retrieved 1 June 2020. 
  132. "Influenza ACIP Vaccine Recommendations". cdc.gov. Retrieved 1 June 2020. 
  133. "FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older". news.sanofi.us. Retrieved 1 June 2020. 
  134. "Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices". cdc.gov. Retrieved 1 June 2020. 
  135. "Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019" (PDF). cdc.gov. Retrieved 1 June 2020. 
  136. "First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response". fda.gov. Retrieved 1 June 2020. 
  137. "DTaP/Tdap/Td ACIP Vaccine Recommendations". cdc.gov. Retrieved 1 June 2020. 
  138. "Immunization Schedules". cdc.gov. Retrieved 1 June 2020. 
  139. "FDA Approves 1st Adjuvanted Quadrivalent Flu Shot For Seniors". precisionvaccinations.com. Retrieved 1 June 2020.